{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:02:28Z","timestamp":1792112548491,"version":"4.4.0"},"reference-count":35,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.jaut.2017.12.015","type":"journal-article","created":{"date-parts":[[2018,1,20]],"date-time":"2018-01-20T00:12:43Z","timestamp":1516407163000},"page":"162-170","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"special_numbering":"C","title":["Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis"],"prefix":"10.1016","volume":"89","author":[{"given":"Eleni","family":"Chouri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nila H.","family":"Servaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cornelis P.J.","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alsya J.","family":"Affandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Cossu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten R.","family":"Hillen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Angiolilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorre S.","family":"Mertens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas L.","family":"van den Hoogen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Silva-Cardoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten","family":"van der Kroef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8593-5240","authenticated-orcid":false,"given":"Nadia","family":"Vazirpanah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catharina G.K.","family":"Wichers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiago","family":"Carvalheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie L.M.","family":"Blokland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Giovannone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Porretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wioleta","family":"Marut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Vigone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joel A.G.","family":"van Roon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Beretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Rossato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy R.D.J.","family":"Radstake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2017.12.015_bib1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1146\/annurev-pathol-011110-130312","article-title":"The pathogenesis of systemic sclerosis","volume":"6","author":"Katsumoto","year":"2011","journal-title":"Annu. Rev. Pathol."},{"key":"10.1016\/j.jaut.2017.12.015_bib2","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1056\/NEJMra0806188","article-title":"Scleroderma","volume":"360","author":"Gabrielli","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.jaut.2017.12.015_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.it.2005.09.004","article-title":"Scleroderma: from cell and molecular mechanisms to disease models","volume":"26","author":"Abraham","year":"2005","journal-title":"Trends Immunol."},{"key":"10.1016\/j.jaut.2017.12.015_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1172\/JCI31139","article-title":"Systemic sclerosis: a prototypic multisystem fibrotic disorder","volume":"117","author":"Varga","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.jaut.2017.12.015_bib5","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.autrev.2010.09.016","article-title":"Fibrosis and immune dysregulation in systemic sclerosis","volume":"10","author":"Chizzolini","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.jaut.2017.12.015_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2014.00123","article-title":"Fibroblasts in fibrosis: novel roles and mediators","volume":"5","author":"Kendall","year":"2014","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.jaut.2017.12.015_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrrheum.2014.128","article-title":"The role of genetics and epigenetics in the pathogenesis of systemic sclerosis","volume":"10","author":"Broen","year":"2014","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.015_bib8","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s00281-015-0504-6","article-title":"Epigenetics and systemic sclerosis","volume":"37","author":"Altorok","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2017.12.015_bib9","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.tcb.2011.12.001","article-title":"Secreted microRNAs: a new form of intercellular communication","volume":"22","author":"Chen","year":"2012","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.jaut.2017.12.015_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1038\/ncb1596","article-title":"Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells","volume":"9","author":"Valadi","year":"2007","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.jaut.2017.12.015_bib11","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nrrheum.2010.81","article-title":"MicroRNAs as biomarkers in rheumatic diseases","volume":"6","author":"Alevizos","year":"2010","journal-title":"Nat. Rev. Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.015_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0030679","article-title":"The majority of microRNAs detectable in serum and saliva is concentrated in exosomes","volume":"7","author":"Gallo","year":"2012","journal-title":"PLos One"},{"key":"10.1016\/j.jaut.2017.12.015_bib13","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1007\/s00281-015-0506-4","article-title":"Update on biomarkers in systemic sclerosis: tools for diagnosis and treatment","volume":"37","author":"Affandi","year":"2015","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.jaut.2017.12.015_bib14","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1038\/emm.2013.71","article-title":"MicroRNAs: their involvement in fibrosis pathogenesis and use as diagnostic biomarkers in scleroderma","volume":"45","author":"Zhu","year":"2013","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.jaut.2017.12.015_bib15","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1002\/art.38098","article-title":"2013 Classification criteria for systemic sclerosis: an american college of rheumatology\/european league against rheumatism collaborative initiative","volume":"65","author":"van den Hoogen","year":"2013","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.jaut.2017.12.015_bib16","first-page":"202","article-title":"Scleroderma (systemic sclerosis): classification, subsets and pathogenesis","volume":"15","author":"Carwile LeRoy","year":"1988","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.015_bib17","first-page":"1573","article-title":"Criteria for the classification of early systemic sclerosis","volume":"28","author":"LeRoy","year":"2001","journal-title":"J.\u00a0Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.015_bib18","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1164\/rccm.200706-877OC","article-title":"Interstitial lung disease in systemic sclerosis: a simple staging system","volume":"177","author":"Goh","year":"2008","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.jaut.2017.12.015_bib19","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/rheumatology\/keu381","article-title":"Role of class II human leucocyte antigens in the progression from early to definite systemic sclerosis","volume":"54","author":"Vigone","year":"2014","journal-title":"Rheumatol. (Oxford)"},{"key":"10.1016\/j.jaut.2017.12.015_bib20","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/jcmm.12293","article-title":"Overexpression of miR-483-5p\/3p cooperate to inhibit mouse liver fibrosis by suppressing the TGF-\u03b2 stimulated HSCs in transgenic mice","volume":"18","author":"Li","year":"2014","journal-title":"J.\u00a0Cell Mol. Med."},{"key":"10.1016\/j.jaut.2017.12.015_bib21","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1002\/art.40163","article-title":"Association of MicroRNA-618 expression with altered frequency and activation of plasmacytoid dendritic cells in patients with systemic sclerosis","volume":"69","author":"Rossato","year":"2017","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.015_bib22","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1093\/rheumatology\/ket254","article-title":"Alteration of circulating miRNAs in SSc: MiR-30b regulates the expression of PDGF receptor \u03b2","volume":"52","author":"Tanaka","year":"2013","journal-title":"Rheumatol. (Oxford)"},{"key":"10.1016\/j.jaut.2017.12.015_bib23","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1111\/j.1365-2230.2011.04158.x","article-title":"Circulating miR-142-3p levels in patients with systemic sclerosis","volume":"37","author":"Makino","year":"2012","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.jaut.2017.12.015_bib24","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ajpath.2012.09.023","article-title":"MiR-150 down-regulation contributes to the constitutive type i collagen overexpression in scleroderma dermal fibroblasts via the induction of integrin \u03b23","volume":"182","author":"Honda","year":"2013","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.12.015_bib25","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1093\/rheumatology\/kes120","article-title":"MicroRNA-92a expression in the sera and dermal fibroblasts increases in patients with scleroderma","volume":"51","author":"Sing","year":"2012","journal-title":"Rheumatol. (Oxford)"},{"key":"10.1016\/j.jaut.2017.12.015_bib26","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.4049\/jimmunol.1200822","article-title":"The downregulation of microRNA let-7a contributes to the excessive expression of type I collagen in systemic and localized scleroderma","volume":"190","author":"Makino","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.jaut.2017.12.015_bib27","doi-asserted-by":"crossref","first-page":"692","DOI":"10.4161\/rna.8.4.16029","article-title":"Population differences in microRNA expression and biological implications","volume":"8","author":"Huang","year":"2011","journal-title":"RNA Biol."},{"key":"10.1016\/j.jaut.2017.12.015_bib28","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/s13075-016-1085-z","article-title":"On behalf of all S. all SRU investigators, Can baseline serum microRNAs predict response to TNF-alpha inhibitors in rheumatoid arthritis?","volume":"18","author":"Cuppen","year":"2016","journal-title":"Arthritis Res. Ther."},{"key":"10.1016\/j.jaut.2017.12.015_bib29","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1007\/s13277-015-3112-0","article-title":"Exosomal onco-miRs from serum of patients with adenocarcinoma of the esophagus: comparison of miRNA profiles of exosomes and matching tumor","volume":"36","author":"Warnecke-Eberz","year":"2015","journal-title":"Tumor Biol."},{"key":"10.1016\/j.jaut.2017.12.015_bib30","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.mce.2010.11.027","article-title":"Coexpression of an intronic microRNA and its host gene reveals a potential role for miR-483-5p as an IGF2 partner","volume":"333","author":"Ma","year":"2011","journal-title":"Mol. Cell. Endocrinol."},{"key":"10.1016\/j.jaut.2017.12.015_bib31","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.2353\/ajpath.2008.071021","article-title":"Insulin-like growth factor-II is increased in systemic sclerosis-associated pulmonary fibrosis and contributes to the fibrotic process via Jun N-terminal kinase- and phosphatidylinositol-3 kinase-dependent pathways","volume":"172","author":"Hsu","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.12.015_bib32","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/1346-8138.13564","article-title":"Possible association of elevated serum collagen type IV level with skin sclerosis in systemic sclerosis","volume":"44","author":"Motegi","year":"2017","journal-title":"J.\u00a0Dermatol."},{"key":"10.1016\/j.jaut.2017.12.015_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/art.39421","article-title":"Endothelial cells expressing endothelial and mesenchymal cell gene products in lung tissue from patients with systemic sclerosis-associated interstitial lung disease","volume":"68","author":"Mendoza","year":"2016","journal-title":"Arthritis Rheumatol."},{"key":"10.1016\/j.jaut.2017.12.015_bib34","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/S0002-9440(10)63685-1","article-title":"Persistent down-regulation of Fli1, a suppressor of collagen transcription, in fibrotic scleroderma skin","volume":"163","author":"Kubo","year":"2003","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jaut.2017.12.015_bib35","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1172\/JCI70577","article-title":"Cardiac fibroblast-derived microRNA passenger strand-enriched exosomes mediate cardiomyocyte hypertrophy","volume":"124","author":"Bang","year":"2014","journal-title":"J.\u00a0Clin. Invest."}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117306649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841117306649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:16:41Z","timestamp":1760257001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841117306649"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":35,"alternative-id":["S0896841117306649"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2017.12.015","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Serum microRNA screening and functional studies reveal miR-483-5p as a potential driver of fibrosis in systemic sclerosis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2017.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}